Our Leadership Team

Joy Yan, M.D., Ph.D

Chief Medical Officer
Joy Yan, M.D., Ph.D., is the Chief Medical Officer of Ambrx. She is an oncology physician- scientist and executive leader with extensive clinical development experience, leading large Phase III global registrational studies from strategic planning, execution, to global submission and approval. She led the success of BMS’ first FDA Pilot Programs (RTOR, Project ORBIS, AAid). She led sBLA submissions and global registrations for FDA (USA), EMA (Europe), PMDA (Japan), TGA (Australia), Health Canada, Korea, Singapore, Swissmedic, Israel, Brazil, etc, and acceleration of NDA filings in NMPA (China). She also has broad clinical development experience at Janssen and Bayer, where she led phase I, II, III studies exploring a variety of MOAs and evaluated NMEs across many tumor types. She has been successful in gaining FDA Fast Track Designation, Breakthrough Therapy Designation, Accelerated Approval, Priority Review, and Orphan Drug Designation on multiple programs with different tumor indications. Dr. Yan completed her Ph.D. in Biochemistry & Molecular Biology at Johns Hopkins University. She received her M.D. from China Medical University; did her residency and clinical fellowship at University of Washington.